New Silkroutes Group Limited, an investment holding company, primarily operates in the healthcare sector in Australia, China, and Singapore. The company engages in the distribution of health supplements and Chinese proprietary medicine; provides clinical management services; health sciences consultancy; dental services; medical and dental supplies; and general medical services. It also owns and operates clinics and provides complementary integrative therapies; runs employee healthcare benefits programmes; offers systems integration services to hospitals and healthcare facilities; and manufactures healthcare consumables. In addition, the company involves in the wholesale and retail trading of crude oil, intermediate fuel oil, and other distillates; and manufacturing of non-woven fabric.